Abstract is: Diether Lambrechts (born 1976) is a Belgian geneticist and professor at the KU Leuven and VIB. He is the director of the Vesalius Research Center. Lambrechts is known for his multidisciplinary approach to dissecting tumor biology. Major scientific contributions include identifying oxygen supply regulation as an anti-cancer treatment strategy. In 2013, Lambrechts was awarded an ERC Consolidator award.
| human | Q5 |
| P2671 | Google Knowledge Graph ID | /g/11cr_ypxdn |
| P496 | ORCID iD | 0000-0002-3429-302X |
| P27 | country of citizenship | Belgium | Q31 |
| P184 | doctoral advisor | Peter Carmeliet | Q2074300 |
| P69 | educated at | Katholieke Universiteit Leuven | Q833670 |
| P108 | employer | Katholieke Universiteit Leuven | Q833670 |
| Wellcome Centre for Human Genetics | Q7981196 | ||
| VIB-KU Leuven Center for Cancer Biology | Q107518790 | ||
| P734 | family name | Lambrechts | Q27257931 |
| Lambrechts | Q27257931 | ||
| Lambrechts | Q27257931 | ||
| P735 | given name | Diether | Q20992528 |
| Diether | Q20992528 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q55196646 | (Epi)genetic variation in ageing of metabolic fitness. |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q52478244 | A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer. |
| Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
| Q45886167 | A genetic Xenopus laevis tadpole model to study lymphangiogenesis |
| Q57095574 | A genetic predisposition score associates with reduced aerobic capacity in response to acute normobaric hypoxia in lowlanders |
| Q29417084 | A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q59384165 | A new approach to imprinting mutation detection in GNAS by Sequenom EpiTYPER system |
| Q95272885 | A new protocol for single-cell RNA-seq reveals stochastic gene expression during lag phase in budding yeast |
| Q122655006 | A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling |
| Q96610089 | A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling |
| Q35870483 | A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q33820857 | A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study |
| Q93009587 | A variant in FTO gene shows association with histological ulceration in cutaneous melanoma |
| Q33947899 | ABCA transporter gene expression and poor outcome in epithelial ovarian cancer |
| Q54978437 | ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib. |
| Q60682625 | Abstract CT135: Uncovering the genomic heterogeneity of multifocal breast cancer |
| Q87400034 | Accelerated lung function decline in smokers: spotlight on vitamin D deficiency |
| Q40885419 | Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response |
| Q33922925 | Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial |
| Q38406780 | Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study |
| Q52647897 | Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. |
| Q90147342 | Age-related changes in DNA methylation affect renal histology and post-transplant fibrosis |
| Q48196121 | Allele-specific DNA methylation reinforces PEAR1 enhancer activity |
| Q48652996 | Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma. |
| Q92627522 | An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates |
| Q90404903 | An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q42371458 | Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci |
| Q36831854 | Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome |
| Q58186373 | Analysis ofFGGYas a risk factor for sporadic amyotrophic lateral sclerosis |
| Q45861140 | Another angiogenic gene linked to amyotrophic lateral sclerosis |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q30276986 | Assessing the genetic architecture of epithelial ovarian cancer histological subtypes |
| Q38373884 | Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach |
| Q35156876 | Assessment of hepatocyte growth factor in ovarian cancer mortality |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q37684409 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q27851709 | Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer |
| Q50306921 | Association of CDH11 with non-syndromic ASD. |
| Q92528135 | Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q39423088 | Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q91676913 | Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells |
| Q115780094 | Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis |
| Q112721569 | BCL(X)L and BCL2 increase the metabolic fitness of breast cancer cells: a single-cell imaging study |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q42458915 | Biology of breast cancer during pregnancy using genomic profiling |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
| Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q35562912 | Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study |
| Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
| Q38766859 | CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells |
| Q91723540 | CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition |
| Q36419325 | CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer |
| Q37524058 | CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations |
| Q120964677 | Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop |
| Q121435198 | Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop |
| Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
| Q38993086 | Centrosome Amplification Is Sufficient to Promote Spontaneous Tumorigenesis in Mammals |
| Q35732707 | Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies |
| Q99564337 | Characterization of stromal tumor-infiltrating lymphocytes and genomic alterations in metastatic lobular breast cancer |
| Q52836791 | Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses. |
| Q61757410 | Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer |
| Q48763915 | Chronic Fatigue Syndrome and DNA Hypomethylation of the Glucocorticoid Receptor Gene Promoter 1F Region: Associations With HPA Axis Hypofunction and Childhood Trauma. |
| Q90425129 | Cigarette Smoke-Induced Emphysema Exhausts Early Cytotoxic CD8+ T Cell Responses against Nascent Lung Cancer Cells |
| Q35782435 | Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer |
| Q49136273 | Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. |
| Q112714201 | Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host |
| Q96576999 | Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q35668946 | Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk |
| Q36490507 | Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). |
| Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q29417145 | Common variants at 19p13 are associated with susceptibility to ovarian cancer |
| Q36255665 | Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer |
| Q115209587 | Common variants in breast cancer risk loci predispose to distinct tumor subtypes |
| Q38809327 | Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q34515012 | Comprehensive fine mapping of chr12q12-14 and follow-up replication identify activin receptor 1B (ACVR1B) as a muscle strength gene |
| Q36026731 | Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
| Q34359322 | Comprehensive mutation analysis in colorectal flat adenomas |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q104795307 | Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts |
| Q34342248 | Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk |
| Q68201163 | Controlling cellular development in a single cell system of Nicotiana |
| Q57022679 | Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q112276907 | Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial |
| Q52853222 | Corrigendum to "Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer" [Eur J Cancer 53 (2016) 51-64]. |
| Q101216461 | Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers |
| Q36213322 | DNA methylation analysis of Homeobox genes implicates HOXB7 hypomethylation as risk factor for neural tube defects |
| Q38458086 | DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature |
| Q97899388 | DNA methylation repels binding of hypoxia-inducible transcription factors to maintain tumor immunotolerance |
| Q89720786 | DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer |
| Q113688640 | Decoding the activated stem cell phenotype of the neonatally maturing pituitary |
| Q42523283 | Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism |
| Q91536735 | Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models |
| Q49537557 | Differences in MWCNT- and SWCNT-induced DNA methylation alterations in association with the nuclear deposition. |
| Q108523613 | Discriminating Mild from Critical COVID-19 by Innate and Adaptive Immune Single-cell Profiling of Bronchoalveolar Lavages |
| Q108502692 | Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages |
| Q38715004 | Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts |
| Q33546654 | Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosis |
| Q50981985 | Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models. |
| Q27851573 | Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis |
| Q46245352 | Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib |
| Q38720533 | Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci |
| Q36322658 | Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy |
| Q24633316 | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer |
| Q57009903 | Epigenetic effects of carbon nanotubes in human monocytic cells |
| Q50460878 | Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatment. |
| Q36487146 | Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk |
| Q50230219 | Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy. |
| Q57319395 | Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer |
| Q87228932 | Erratum: Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma |
| Q42339906 | Erratum: Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations |
| Q97906478 | Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology |
| Q92953582 | Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing |
| Q50938903 | Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models. |
| Q36966218 | Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study |
| Q36295068 | Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting |
| Q64110801 | Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
| Q33620795 | Exome sequencing reveals HINT1 mutations as a cause of distal hereditary motor neuropathy |
| Q112643148 | Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression |
| Q95937680 | Exposure-response analysis of endoxifen serum concentrations in early-breast cancer |
| Q92260606 | Expression of immune-related genes in rectum and colon descendens of Irritable Bowel Syndrome patients is unrelated to clinical symptoms |
| Q36203396 | Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q34805622 | FISH analysis of PTEN in endometrial carcinoma. Comparison with SNP arrays and MLPA. |
| Q90348408 | Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib |
| Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q37002930 | Five endometrial cancer risk loci identified through genome-wide association analysis |
| Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q34031757 | Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q52571296 | GLI2 promoter hypermethylation in saliva of children with a respiratory allergy. |
| Q36956156 | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer |
| Q57670523 | Gain of function of mutant p53 by coaggregation with multiple tumor suppressors |
| Q90130072 | Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer |
| Q33242612 | Gene prioritization through genomic data fusion |
| Q47681304 | Gene-based interaction analysis shows GABAergic genes interacting with parenting in adolescent depressive symptoms. |
| Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
| Q62583319 | Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk |
| Q37389405 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
| Q115209620 | Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus |
| Q92465200 | Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration |
| Q38123207 | Genetic changes in nonepithelial ovarian cancer |
| Q52859508 | Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer. |
| Q62583597 | Genetic markers of bevacizumab-induced hypertension |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
| Q41611518 | Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes |
| Q46905780 | Genetic predisposition scores associate with muscular strength, size, and trainability |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q33422082 | Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer |
| Q33405790 | Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC). |
| Q48848074 | Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy. |
| Q48695033 | Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients. |
| Q45841556 | Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome |
| Q46721561 | Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q42224417 | Genetic variation in caveolin-1 affects survival after lung transplantation |
| Q51725362 | Genetic variation in immunoglobulin G receptor affects survival after lung transplantation. |
| Q43837678 | Genetic variation in interleukin-17 receptor A is functionally associated with chronic rejection after lung transplantation |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q48858412 | Genetic variation in the lymphotoxin-α (LTA)/tumour necrosis factor-α (TNFα) locus as a risk factor for idiopathic achalasia. |
| Q35937600 | Genetics in zebrafish, mice, and humans to dissect congenital heart disease: insights in the role of VEGF. |
| Q37310665 | Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis |
| Q57863277 | Genome dynamics of the human embryonic kidney 293 (HEK293) lineage in response to cell biology manipulations |
| Q34200605 | Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q36218993 | Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium |
| Q108396430 | Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2 |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q37202841 | Genome-wide association study for ovarian cancer susceptibility using pooled DNA. |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q29417135 | Genome-wide association study identifies a common variant associated with risk of endometrial cancer |
| Q36024614 | Genome-wide association study identifies a possible susceptibility locus for endometrial cancer |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q33778612 | Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. |
| Q51352672 | Genomic Characterisation and Response to Trastuzumab and Paclitaxel in Advanced or Recurrent HER2-positive Endometrial Carcinoma. |
| Q40880815 | Genomic Characterization of Primary Invasive Lobular Breast Cancer |
| Q59566871 | Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility |
| Q38823212 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk |
| Q37269294 | Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1. |
| Q54433238 | Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease. |
| Q38985425 | Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma |
| Q49822291 | Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer. |
| Q35114576 | Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer |
| Q36916243 | Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer |
| Q114182677 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis |
| Q57009889 | Global and gene-specific DNA methylation effects of different asbestos fibres on human bronchial epithelial cells |
| Q47560340 | Glucocorticoid receptor DNA methylation and childhood trauma in chronic fatigue syndrome patients |
| Q46597996 | HIF-1α Promotes Glutamine-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics to Support Postimplantation Bone Cell Survival |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q36933962 | Heterogeneity in motoneuron disease |
| Q50487052 | High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma. |
| Q36547873 | Huvariome: a web server resource of whole genome next-generation sequencing allelic frequencies to aid in pathological candidate gene selection |
| Q104571967 | IL1β promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q37006170 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. |
| Q35233872 | Identification and prioritization of NUAK1 and PPP1CC as positional candidate loci for skeletal muscle strength phenotypes |
| Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
| Q112717190 | Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer |
| Q61757407 | Identification of a novel predictive genomic biomarker for response to combination bevacizumab in metastatic colorectal cancer (mCRC) |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q35541663 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q93230171 | Identification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations |
| Q49049921 | Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. |
| Q57938418 | Impaired Autonomic Regulation of Resistance Arteries in Mice With Low Vascular Endothelial Growth Factor or Upon Vascular Endothelial Growth Factor Trap Delivery |
| Q39304648 | Implementing liquid biopsies into clinical decision making for cancer immunotherapy |
| Q114866649 | Improved metabolite identification with MIDAS and MAGMa through MS/MS spectral dataset-driven parameter optimization |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q89730344 | Induction and recovery of CpG site specific methylation changes in human bronchial cells after long-term exposure to carbon nanotubes and asbestos |
| Q43624719 | Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study |
| Q47781970 | Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease |
| Q37684424 | Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q38730013 | Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy. |
| Q24338659 | Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties |
| Q47611840 | Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways. |
| Q51634771 | Interleukin-17 receptor polymorphism predisposes to primary graft dysfunction after lung transplantation. |
| Q38803904 | International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and Hopes |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q58428552 | Ischemia-Induced DNA Hypermethylation during Kidney Transplant Predicts Chronic Allograft Injury |
| Q50702322 | It's T Time for Normal Blood Vessels. |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q94852396 | K-ras mutations and cetuximab in colorectal cancer |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q29417023 | Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease |
| Q37725393 | Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q61773030 | Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next? |
| Q39048511 | Limited potential of genetic predisposition scores to predict muscle mass and strength performance in Flemish Caucasians between 19 and 73 years of age. |
| Q95832213 | Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer |
| Q46189262 | Lineage-specific functions of TET1 in the postimplantation mouse embryo. |
| Q89901001 | Lipid availability determines fate of skeletal progenitor cells via SOX9 |
| Q64076294 | Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer |
| Q61757404 | Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab |
| Q24673521 | Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q38080828 | Markers of response for the antiangiogenic agent bevacizumab |
| Q82415696 | Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1 |
| Q51039243 | Medicine: genetic spotlight on a blood defect. |
| Q91218975 | Melanoma susceptibility variant rs869330 in the MTAP gene is associated with melanoma outcome |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q98772941 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer |
| Q97528612 | Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival |
| Q36333368 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
| Q45876779 | Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype |
| Q34297140 | Methylation defect in imprinted genes detected in patients with an Albright's hereditary osteodystrophy like phenotype and platelet Gs hypofunction |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q45809407 | Microglial upregulation of progranulin as a marker of motor neuron degeneration |
| Q52965839 | Microsatellite instable and microsatellite stable primary endometrial carcinoma cells and their subcutaneous and orthotopic xenografts recapitulate the characteristics of the corresponding primary tumor. |
| Q34077139 | Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks |
| Q42185079 | Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment. |
| Q38888628 | Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer |
| Q37820541 | Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials. |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q35123683 | Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors |
| Q43720808 | Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas |
| Q26799669 | Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk |
| Q48416261 | Neurogenic Radial Glia-like Cells in Meninges Migrate and Differentiate into Functionally Integrated Neurons in the Neonatal Cortex |
| Q42719160 | Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons |
| Q37078102 | Neurovascular signalling defects in neurodegeneration |
| Q42281051 | Newborn genome-wide DNA methylation in association with pregnancy anxiety reveals a potential role for GABBR1. |
| Q30275832 | No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival |
| Q34057961 | No association between FTO or HHEX and endometrial cancer risk |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q28297622 | Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration |
| Q36027025 | Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium |
| Q36871009 | Olmsted syndrome: exploration of the immunological phenotype |
| Q34854354 | Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report |
| Q42629171 | Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing. |
| Q112648846 | Organoids from human tooth showing epithelial stemness phenotype and differentiation potential |
| Q40534552 | Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q114871094 | PHGDH heterogeneity potentiates cancer cell dissemination and metastasis |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q46051180 | PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer |
| Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
| Q92443313 | Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer |
| Q92353560 | Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening |
| Q37730440 | Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy |
| Q57188235 | Phenotype molding of stromal cells in the lung tumor microenvironment |
| Q36546673 | Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma |
| Q33810500 | Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations |
| Q96226209 | Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome |
| Q29615729 | Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study |
| Q44670943 | Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer |
| Q35177861 | Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q36915870 | Polymorphisms in inflammation pathway genes and endometrial cancer risk |
| Q33921008 | Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium |
| Q52675041 | Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors. |
| Q99351966 | Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic Abnormalities |
| Q92055460 | Prediction and clinical utility of a contralateral breast cancer risk model |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q91832507 | Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts |
| Q44006487 | Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs |
| Q40397279 | Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium |
| Q45929878 | Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users. |
| Q35018327 | Progesterone receptor gene variants and risk of endometrial cancer |
| Q34994583 | Prognostic significance of POLE proofreading mutations in endometrial cancer. |
| Q36527176 | Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q61821529 | Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis |
| Q90285520 | RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue |
| Q114182625 | Rare germline copy number variants (CNVs) and breast cancer risk |
| Q101131536 | Regeneration Defects in Yap and Taz Mutant Mouse Livers are Caused by Bile Duct Disruption and Cholestasis |
| Q37551644 | Relief of hypoxia by angiogenesis promotes neural stem cell differentiation by targeting glycolysis |
| Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
| Q37624504 | Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10 |
| Q37431132 | Role and therapeutic potential of VEGF in the nervous system |
| Q28513935 | Role of Gas6 in erythropoiesis and anemia in mice |
| Q24304277 | Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 |
| Q34778250 | Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. |
| Q121765981 | S3.3d Influenza versus COVID-19-associated pulmonary aspergillosis: Profiling lower respiratory tract epithelial and myeloid innate immunity in patient samples |
| Q123026748 | SYST-25 MICROGLIA-SECRETED LIPID SPECIES DRIVE GLIOMA INVASION |
| Q35875799 | Sculpting heart valves with NFATc and VEGF. |
| Q57025360 | Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis |
| Q91223440 | Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis |
| Q36747333 | Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting |
| Q34184913 | Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins |
| Q36089391 | Shared genetics underlying epidemiological association between endometriosis and ovarian cancer |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q98179213 | Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy |
| Q36663566 | Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib |
| Q91954599 | Solar Lentigines are Associated with Better Outcome in Cutaneous Melanoma |
| Q52336141 | Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response. |
| Q52873401 | Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer. |
| Q36976208 | Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer |
| Q37067203 | Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab |
| Q92522162 | Subsequent Event Risk in Individuals With Established Coronary Heart Disease |
| Q51509416 | Successful application of endoscopic ultrasound-guided fine needle biopsy to establish pancreatic patient-derived tumor xenografts: a pilot study. |
| Q48460372 | Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy. |
| Q53762480 | TET enzymes as oxygen-dependent tumor suppressors: exciting new avenues for cancer management. |
| Q33566957 | TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |
| Q49832422 | Tamoxifen metabolism and efficacy in breast cancer- a prospective multicentre trial. |
| Q103788261 | Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies |
| Q43223136 | The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema |
| Q36921422 | The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q38847144 | The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts |
| Q38701049 | The Emerging Role of DNA Methylation in Kidney Transplantation: A Perspective |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q84575138 | The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients |
| Q35781316 | The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients |
| Q50852837 | The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo. |
| Q48106804 | The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology |
| Q87224277 | The diagnostic value of next generation sequencing in familial nonsyndromic congenital heart defects |
| Q33864284 | The footprint of the ageing stroma in older patients with breast cancer |
| Q57292400 | The genetic landscape of 5T models for multiple myeloma |
| Q91253691 | The genetic landscape of 87 ovarian germ cell tumors |
| Q91348900 | The genomic landscape of nonsmall cell lung carcinoma in never smokers |
| Q37703901 | The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment |
| Q35024008 | The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing |
| Q48381437 | The role of fatty acid β-oxidation in lymphangiogenesis |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q51070101 | Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies. |
| Q33385474 | Thrombomodulin mutations in atypical hemolytic-uremic syndrome |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q52901124 | Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis. |
| Q45879717 | Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. |
| Q41662165 | Tumors smother their epigenome |
| Q37463942 | Tumour hypoxia causes DNA hypermethylation by reducing TET activity |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q36404728 | Uncovering the genomic heterogeneity of multifocal breast cancer |
| Q46637686 | Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). |
| Q55647188 | Use of different genetic predisposition score techniques to predict muscle mass and muscle function over the adult life span in Flemish Caucasians. |
| Q34539899 | VEGF at the neurovascular interface: therapeutic implications for motor neuron disease |
| Q45863485 | VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death |
| Q34275084 | VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials |
| Q34342111 | VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures |
| Q45857957 | VEGF: a modifier of the del22q11 (DiGeorge) syndrome? |
| Q35791985 | VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS? |
| Q24302846 | VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection |
| Q54448748 | VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis. |
| Q39601152 | Validation of VEGFR1 rs9582036 as predictive biomarker in metastatic clear-cell renal cell carcinoma patients treated with sunitinib |
| Q56342454 | Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility |
| Q34562154 | Variants in the 15q24/25 locus associate with lung function decline in active smokers |
| Q33847791 | Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer |
| Q39563738 | Vascular endothelial growth factor pathway in endometriosis: genetic variants and plasma biomarkers |
| Q85056214 | Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene |
| Q84206299 | Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency |
| Q24623830 | Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis |
| Q50899120 | Why should results from metastatic trials no longer matter for early-stage disease? |
| Q38759968 | p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity |
| Q56334023 | rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology |
| Q2074300 | Peter Carmeliet | doctoral student | P185 |
| Diether Lambrechts | wikipedia | |
| Persian (fa / Q9168) | دیتر لامبراشت | wikipedia |
Search more.